These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 6276950

  • 1. Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro.
    Swanson BN, Hichens M, Mojaverian P, Ferguson RK, Vlasses PH, Dudash M.
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):525-36. PubMed ID: 6276950
    [Abstract] [Full Text] [Related]

  • 2. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM, Sweet CS, Ulm EH, Backlund EP, Morris AA, Weitz D, Bohn DL, Wenger HC, Vassil TC, Stone CA.
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS.
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [Abstract] [Full Text] [Related]

  • 4. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
    Johnston CI, Jackson B, McGrath B, Matthews G, Arnolda L.
    J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
    [Abstract] [Full Text] [Related]

  • 5. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR, Cohen DM, Essenburg AD, Major TC, Mertz TE, Ryan MJ.
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [Abstract] [Full Text] [Related]

  • 6. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.
    Cohen ML, Kurz KD, Schenck KW.
    J Pharmacol Exp Ther; 1983 Jul; 226(1):192-6. PubMed ID: 6306224
    [No Abstract] [Full Text] [Related]

  • 7. Total serum angiotensin converting enzyme activity in rats and dogs after enalapril maleate (MK-421).
    Ulm EH, Vassil TC.
    Life Sci; 1982 Apr 05; 30(14):1225-30. PubMed ID: 6283285
    [Abstract] [Full Text] [Related]

  • 8. Measurements of serum ACE activity in vitro after administration of enalapril in man cannot reflect inhibition of the enzyme in vivo.
    Weisser K, Schloos J.
    Methods Find Exp Clin Pharmacol; 1993 Apr 05; 15(6):413-8. PubMed ID: 8231461
    [Abstract] [Full Text] [Related]

  • 9. Correlation between ACE activity and mean blood pressure in Iranian normotensive subjects after oral administration of a single dose of enalapril.
    Ziai SA, Seyedhosseini D, Taiebi L, Salekmoghadam E, Mahmoudian M.
    Acta Physiol Hung; 2000 Apr 05; 87(2):153-9. PubMed ID: 11205963
    [Abstract] [Full Text] [Related]

  • 10. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
    Biollaz J, Schelling JL, Jacot Des Combes B, Brunner DB, Desponds G, Brunner HR, Ulm EH, Hichens M, Gomez HJ.
    Br J Clin Pharmacol; 1982 Sep 05; 14(3):363-8. PubMed ID: 6289859
    [Abstract] [Full Text] [Related]

  • 11. The physiological disposition and metabolism of enalapril maleate in laboratory animals.
    Tocco DJ, deLuna FA, Duncan AE, Vassil TC, Ulm EH.
    Drug Metab Dispos; 1982 Sep 05; 10(1):15-9. PubMed ID: 6124377
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
    Ryan MJ, Boucher DM, Cohen DM, Essenburg AD, Major TC, Mertz TE, Olszewski BJ, Randolph AE, Singer RM, Kaplan HR.
    J Pharmacol Exp Ther; 1984 Feb 05; 228(2):312-8. PubMed ID: 6319675
    [Abstract] [Full Text] [Related]

  • 13. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G, Mario B, Lopez G, Evangelista S, Manzini S, Maggi CA.
    Vascul Pharmacol; 2009 Feb 05; 50(5-6):166-70. PubMed ID: 19344651
    [Abstract] [Full Text] [Related]

  • 14. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH, Vagelos RH, Yee YG, Fowler MB.
    Am Heart J; 2004 Nov 05; 148(5):889-94. PubMed ID: 15523323
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay.
    Jackson B, Cubela R, Johnston CI.
    J Cardiovasc Pharmacol; 1987 Jun 05; 9(6):699-704. PubMed ID: 2442537
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S, Takeyama K, Fukuya F, Nagai R, Hosoki K, Nishimura K, Deguchi T, Karasawa T.
    Arzneimittelforschung; 1995 Aug 05; 45(8):853-8. PubMed ID: 7575746
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
    Sybertz EJ, Baum T, Ahn HS, Nelson S, Eynon E, Desiderio DM, Pula K, Becker F, Sabin C, Moran R, Vander Vliet G, Kastner B, Smith E.
    J Cardiovasc Pharmacol; 1983 Aug 05; 5(4):643-54. PubMed ID: 6193364
    [Abstract] [Full Text] [Related]

  • 18. Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man.
    Ulm EH.
    Drug Metab Rev; 1983 Aug 05; 14(1):99-110. PubMed ID: 6301792
    [Abstract] [Full Text] [Related]

  • 19. Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.
    Jackson B, McGrath BP, Johnston CI.
    Clin Exp Pharmacol Physiol Suppl; 1982 Aug 05; 7():99-104. PubMed ID: 6291832
    [Abstract] [Full Text] [Related]

  • 20. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
    Nussberger J, Brunner DB, Waeber B, Brunner HR.
    J Lab Clin Med; 1984 Feb 05; 103(2):304-12. PubMed ID: 6319516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.